Femasys (FEMY) Non Operating Interest Expenses (2020 - 2026)
Femasys' (FEMY) quarterly Non Operating Interest Expenses came in at $186050.0 in Q2 2026, down 62.15% on a YoY basis from $491500.0 in Q2 2025, and down 62.15% quarter-over-quarter from $491500.0 in Q2 2025.
Powered by 
Analysis
Femasys (FEMY) Non Operating Interest Expenses (2020 - 2026) Analysis & Trends
Femasys (FEMY) has reported Non Operating Interest Expenses for 7 consecutive years, with $186050.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Interest Expenses fell 62.15% year-over-year to $186050.0; the trailing twelve-month figure through Jun 2026 stood at $1.6 million (down 12.59% YoY), and the FY2025 full-year result was $1.9 million, up 17.93% from the prior year.
- Non Operating Interest Expenses fell to $186050.0 in Q2 2026 per FEMY's latest filing, from $491500.0 in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at $491500.0 in Q2 2025 and bottomed at $198.0 in Q2 2023.
- Historically, Non Operating Interest Expenses has averaged $194628.5 across 5 years, with a median of $155487.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Non Operating Interest Expenses sank 77.58% in 2023, then jumped 196016.67% in 2024.
- Over 5 years, Non Operating Interest Expenses stood at $3842.0 in 2022, then surged by 3947.03% to $155487.0 in 2023, then surged by 183.25% to $440422.0 in 2024, then climbed by 11.6% to $491500.0 in 2025, then sank by 62.15% to $186050.0 in 2026.
- According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $186050.0, $491500.0, and $459449.0 for Q2 2026, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Femasys | 9.01 Mn | 7.57 Mn | 189,391.00 | 186,050.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 186,050.00 |
| Jun 30, 2025 | 491,500.00 |
| Mar 31, 2025 | 459,449.00 |
| Dec 31, 2024 | 440,422.00 |
| Sep 30, 2024 | 413,290.00 |
| Jun 30, 2024 | 388,311.00 |
| Mar 31, 2024 | 361,552.00 |
| Dec 31, 2023 | 155,487.00 |
| Sep 30, 2023 | 8,033.00 |
| Jun 30, 2023 | 198.00 |
| Mar 31, 2023 | 1,672.00 |
| Dec 31, 2022 | 3,842.00 |
| Sep 30, 2022 | 6,005.00 |
| Jun 30, 2022 | 883.00 |
| Mar 31, 2022 | 2,734.00 |
| Dec 31, 2021 | 4,680.00 |
| Sep 30, 2021 | 7,055.00 |
| Jun 30, 2021 | 3,643.00 |
| Mar 31, 2021 | 3,848.00 |
| Dec 31, 2020 | 3,460.00 |